Columbia Mailman School has long been a leader in climate and health research and education. In 2011, the School launched its Climate and Health program, the first in a school of public health.
Shares of Biogen and other drugmakers researching Alzheimer’s disease soared Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study.
Sharply rising cases of some sexually transmitted diseases — including a 26% rise in new syphilis infections reported last year — are prompting U.S. health officials to call for new prevention and treatment efforts.
This month, the Department of Veterans Affairs published “Whole Heath System Approach to Long COVID” — a guidebook for caring for Veterans with Long COVID.
Hallucinogen use has increased since 2015, overall and particularly among adults 26 and older, while use decreased in adolescents aged 12–17 years according to a new study by Columbia University Mailman School of Public Health and Columbia University Irving Medical Center.